Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes
2 other identifiers
interventional
147
1 country
1
Brief Summary
Our hypothesis is that aggressive preconception weight loss in obese women will improve the metabolic health of the mother and the intrauterine environment. An optimized developmental environment will normalize fetal growth and improve clinical fetal and infant outcomes, and theoretically reduce future susceptibility to obesity and cardiometabolic disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2017
CompletedFirst Posted
Study publicly available on registry
August 9, 2017
CompletedStudy Start
First participant enrolled
April 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2025
CompletedResults Posted
Study results publicly available
September 4, 2026
CompletedSeptember 4, 2026
July 1, 2026
7.2 years
August 5, 2017
July 24, 2026
September 2, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Preconception Weight Loss
Primary pre-specified outcome is BMI change (kg/m2) after dietary intervention. Trained staff will measure height and weight to the nearest .1cm and .1kg using a wall-mounted, precision stadiometer and calibrated digital scale. BMI will be calculated (kg/m2).
Baseline to conception (up to 68 weeks post enrollment)
Maternal Diagnosis
Gestational diabetes or hypertensive disorders in pregnancy
Throughout pregnancy (up to 108 weeks post enrollment)
Offspring Body Fat Mass
Percentage body fat (adiposity) in the offspring of women randomized to Very Low Energy Diet (VLED) compared to those randomized to Standard of Care (SOC). Body composition will be assessed by PeaPod (fat mass in grams).
Delivery (up to 108 weeks post enrollment)
Secondary Outcomes (3)
Fetal Growth Will be Assessed by Ultrasound
2nd trimester (up to 90 weeks post enrollment) and 3rd trimester (up to 102 weeks post enrollment) of pregnancy
Ponderal Index
Delivery (up to 108 weeks post enrollment) up to 12 month post delivery follow-up (up to 160 weeks post enrollment)
Mode of Delivery
Delivery (up to 108 weeks post enrollment)
Other Outcomes (5)
Intrauterine Abnormalities
Throughout pregnancy
Metabolome
Delivery
Cord Blood Related to Neonate Outcomes
Delivery
- +2 more other outcomes
Study Arms (3)
Obese - Very low energy diet (VLED)
OTHERParticipants will adopt a very-low energy diet
Obese - Standard of care (SOC)
ACTIVE COMPARATORParticipants will receive the standard of care for obese dietary education and advice to incorporate a low-calorie food based diet
LEAN
NO INTERVENTIONHealthy weight women followed in parallel. No dietary intervention prior to conceiving.
Interventions
Standard consultation with registered dietitian to determine appropriate caloric deficit for a low calorie diet, education and advice to achieve weight loss in obese women. Standard of care for normal weight women
Structured, intensive dietary intervention using liquid meal replacements aimed at providing 800 kcal/day with a weight loss goal of 15% from baseline
Eligibility Criteria
You may qualify if:
- BMI \> 30 ≤ 45 for obese participants OR
- BMI ≤ 25 for healthy body weight participants
- No known infertility
- No known risk factors for tubal disease
You may not qualify if:
- Significant medical co-morbidities (e.g. heart, kidney, liver, autoimmune disease)
- Significant anemia
- Cancer other than minor skin cancers
- Conditions that would complicate pregnancy
- Recent use of anti-obesity drugs or appetite suppressants
- Previous bariatric surgery
- Endometriosis AFS (American Fertility Society classification class III or IV)
- Progesterone \> 10 IU/ml
- Current pregnancy
- Use of sperm donor
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48106, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Amy E Rothberg
- Organization
- University of Michigan
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Rothberg, MD
University of Michigan
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Project Investigator
Study Record Dates
First Submitted
August 5, 2017
First Posted
August 9, 2017
Study Start
April 10, 2018
Primary Completion
June 14, 2025
Study Completion
August 29, 2025
Last Updated
September 4, 2026
Results First Posted
September 4, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share